Work

Baseline Characteristics of ASSIST: Phase 2 Crossover Trial of Atrasentan in Adults with IgAN on SGLT2 Inhibitors

Year: 2025

Type: article

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.20251m9dyn78

Authors: Amy K. Mottl, Gianna Mastroianni-Kirsztajn, Irene L. Noronha, Soo Kun Lim, Jose L. Gorriz, Sradha S. Kotwal, Sung Gyun Kim, Jonathan Barratt, Yasmin Brahmbhatt, Greggory Joseph Housler, Rong Jiao, Hiddo Jan L. Heerspink

Institutions: University of North Carolina at Chapel Hill, Universidade Federal de São Paulo, Universidade de São Paulo, University of Malaya, Universitat de València, Hospital Clínico Universitario de Valencia, Prince of Wales Hospital, The George Institute for Global Health, Hallym University Sacred Heart Hospital, University of Leicester, University Medical Center Groningen

Language: English

Topic: Renal Diseases and Glomerulopathies

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416066792

FWCI: 0.701

Cites:

Cited by: 1

Related to: 10